For research use only. Not for therapeutic Use.
(Rac)-Rotigotine-d3 hydrochloride(Cat No.:S000457) is a deuterated version of (Rac)-rotigotine, where three hydrogen atoms are replaced with deuterium, enhancing its stability for pharmacokinetic and metabolic studies. Rotigotine is a dopamine agonist used primarily in the treatment of Parkinson’s disease and restless legs syndrome. It mimics dopamine, a neurotransmitter, that helpinghelps to manage symptoms related to these conditions. The racemic mixture includes both enantiomers of rotigotine. The hydrochloride form improves solubility. The deuterated version, (Rac)-Rotigotine-d3 hydrochloride, is particularly valuable in research for investigating the drug’s metabolism and long-term behavior in the body.
Catalog Number | S000457 |
CAS Number | 1215846-20-0 |
Molecular Formula | C19H23D3ClNOS |
Purity | ≥95% |
IUPAC Name | 6-[2-thiophen-2-ylethyl(3,3,3-trideuteriopropyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol;hydrochloride |
InChI | InChI=1S/C19H25NOS.ClH/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21;/h3-7,13,16,21H,2,8-12,14H2,1H3;1H/i1D3; |
InChIKey | CEXBONHIOKGWNU-NIIDSAIPSA-N |
SMILES | CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O.Cl |